Clinical trial
Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone…
NCT00232947 · ID Biomedical Corporation, Quebec, Industry · Completed
Key facts
| NCT number | NCT00232947 |
|---|---|
| Title | Study Comparing Immune Response to, and Safety of, Fluviral and Fluzone Influenza Vaccines in Persons 50 y.o. and Over |
| Official title | A Non-Inferiority Comparison of Fluviral™ Influenza Vaccine to a U.S. Licensed Inactivated Split-Virion Vaccine (Fluzone®) in Adults ≥ 50 Years Old Living in the Community |
| Lead sponsor | ID Biomedical Corporation, Quebec, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Influenza virus vaccine (Fluviral), Influenza virus vaccine (Fluzone) |
| Enrollment | 900 |
| Start date | Oct 1, 2005 |
| Completion | Feb 1, 2006 |
| First posted | Oct 5, 2005 |
| Last update posted | Jan 22, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: